US stock · Healthcare sector · Diagnostics & Research
Company Logo

CareDx, Inc

CDNANASDAQ

22.09

USD
+0.17
(+0.78%)
After Hours Market
-23.42P/E
368Forward P/E
-1.13P/E to S&P500
1.176BMarket CAP
- -Div Yield
Scale: |
View:
Currency: USD, in millions
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Income Statement
Revenue
20
22
27
28
41
48
77
127
192
296
COGS
8
9
9
10
21
21
33
45
63
97
Gross Profit
13
13
19
18
20
27
44
82
129
199
Gross Profit Ratio
61.22%
58.92%
68.72%
63.50%
48.02%
55.78%
56.92%
64.23%
67.16%
67.14%
Operating Expenses
15
14
19
30
44
44
58
106
147
229
R&D Expenses
5
3
4
9
12
12
15
31
49
77
Selling, G&A Exp.
10
11
15
21
32
32
44
75
103
152
General and Admin. Exp.
5
5
8
12
21
19
22
37
49
75
Selling and Marketing Exp.
5
6
6
8
11
13
22
39
54
77
Other Expenses
- -
- -
- -
- -
- -
- -
- -
- -
(5)
- -
COGS and Expenses
23
23
27
40
65
65
91
152
210
326
Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
0
0
Interest Expense
3
2
2
2
2
6
4
- -
- -
- -
Depreciation and Amortization
1
1
1
1
3
4
4
6
10
12
EBITDA
(1)
(1)
2
(11)
(36)
(48)
(40)
(18)
(10)
(20)
EBITDA ratio
(6.28)%
(3.30)%
6.99%
(40.24)%
(89.33)%
(98.41)%
(52.60)%
(14.50)%
(5.31)%
(6.82)%
Operating Income
(2)
(1)
1
(12)
(37)
(20)
(16)
(25)
(23)
(30)
Operating Income ratio
(11.45)%
(3.88)%
4.58%
(42.40)%
(91.88)%
(42.00)%
(20.35)%
(19.31)%
(11.72)%
(10.03)%
Total Other Income Exp.(Gains)
(3)
(3)
(2)
(2)
(4)
(37)
(33)
1
3
(2)
Income Before Tax
(5)
(4)
(1)
(14)
(41)
(57)
(48)
(24)
(20)
(32)
Income Before Tax ratio
(24.74)%
(16.03)%
(2.63)%
(48.70)%
(101.80)%
(118.51)%
(62.97)%
(18.85)%
(10.28)%
(10.83)%
Income Tax Expense (Gain)
- -
- -
(2)
- -
(2)
(2)
(1)
(2)
(1)
(1)
Net Income
(5)
(4)
1
(14)
(39)
(55)
(47)
(22)
(19)
(31)
Net Income Ratio
(24.74)%
(16.03)%
2.86%
(48.70)%
(97.14)%
(114.79)%
(61.06)%
(17.29)%
(9.74)%
(10.34)%
EPS
(0.69)
(0.41)
0.13
(1.16)
(2.39)
(2.38)
(1.31)
(0.52)
(0.40)
(0.58)
EPS Diluted
(0.69)
(0.41)
0.10
(1.16)
(2.39)
(2.38)
(1.31)
(0.52)
(0.40)
(0.58)
Weighted Avg. Shares Outs.
7
7
6
12
16
23
36
42
46
53
Weighted Avg. Shares Outs. Dil.
7
7
9
12
16
23
36
42
46
53
Balance Sheet
Cash and Cash Equivalents
6
5
36
30
17
17
65
38
135
348
Short-Term Investments
- -
- -
- -
- -
- -
- -
- -
- -
90
- -
Cash & Short-Term Investments
6
5
36
30
17
17
65
38
225
348
Net Receivables
1
2
3
2
3
3
10
24
35
60
Inventory
1
1
1
1
5
6
5
6
10
17
Other Current Assets
0
0
1
1
1
1
2
4
4
8
Total Current Assets
8
8
40
34
27
27
81
72
273
433
PP&E
2
2
2
2
3
2
4
9
26
40
Goodwill
- -
- -
12
12
14
12
12
24
24
37
Intangible Assets
- -
- -
7
7
33
33
33
46
44
50
Goodwill and Intangible Assets
- -
- -
19
19
47
45
45
69
68
87
Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Non-Current Assets
0
0
0
0
0
10
0
1
1
6
Total Non-Current Assets
2
2
21
21
50
57
50
80
95
133
Other Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
10
10
61
56
77
84
131
152
369
567
Accounts Payable
1
1
1
2
3
3
5
6
10
13
Short-Term Debt
2
5
6
3
23
16
0
3
2
4
Tax Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Deferred Revenue
1
0
1
0
0
0
0
4
24
4
Other Current Liabilities
3
2
3
5
15
23
15
23
34
56
Total Current Liabilities
6
8
11
10
41
43
20
35
69
77
Long-Term Debt
13
11
5
13
1
18
- -
- -
16
17
Deferred Revenue
- -
2
0
1
1
1
1
- -
- -
- -
Deferred Tax Liabilities
- -
- -
- -
- -
6
5
3
2
1
0
Other Non-Current Liabilities
137
140
3
2
8
23
12
16
4
6
Total Non-Current Liabilities
151
153
9
16
16
47
15
18
22
23
Other Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Lease Obligations
0
0
0
0
0
0
0
3
18
21
Total Liabilities
157
161
20
26
57
90
35
53
91
101
Preferred Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
(157)
(160)
(159)
(173)
(213)
(268)
(312)
(334)
(353)
(383)
Other Compreh. Income(Loss)
(10)
(11)
(11)
(12)
(4)
(2)
(4)
(5)
(2)
(5)
Other Total Stockhold. Equity
20
20
212
214
236
264
412
438
632
854
Total Stockholders Equity
(147)
(151)
41
29
19
(6)
96
99
278
466
Total Liab.&Stockhold. Equity
10
10
61
56
76
83
131
152
369
567
Minority Interest
- -
- -
- -
- -
0
0
- -
- -
- -
- -
Total Liabilities & Equity
10
10
61
56
77
84
131
152
369
567
Cash Flow Statement
Net Income
(5)
(4)
1
(14)
(39)
(55)
(47)
(22)
(19)
(31)
Depreciation and Amortization
1
1
1
1
3
4
4
6
10
12
Deferred Income Tax
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Stock Based Compensation
0
0
1
1
2
2
7
22
23
36
Change in Working Capital
2
1
(2)
2
1
(1)
(1)
(10)
17
(41)
Accounts Receivable
(0)
(1)
(0)
0
1
(0)
(4)
(13)
(10)
(24)
Inventory
(0)
0
(0)
(0)
0
1
0
(1)
(3)
(7)
Accounts Payable
(0)
(0)
1
0
(1)
0
(0)
1
4
2
Other Working Capital
1
1
29
24
(1)
(2)
3
2
5
6
Other Non-Cash Items
0
1
(3)
(0)
17
37
32
2
2
4
Cash Provided by Operating Activities
(2)
(1)
(3)
(10)
(17)
(14)
(4)
(3)
33
(19)
CAPEX
(0)
(0)
(1)
(1)
(1)
(0)
(7)
(3)
(10)
(20)
Acquisitions Net
- -
- -
(1)
- -
- -
(6)
(1)
(18)
- -
(15)
Purchases of Investments
(2)
- -
- -
- -
- -
- -
- -
(1)
(90)
(6)
Sales/Maturities of Investments
2
- -
- -
- -
- -
- -
- -
- -
- -
89
Other Investing Activities
- -
- -
- -
- -
(21)
(0)
(5)
(3)
(10)
(20)
Cash Used for Investing Activities
1
(0)
(1)
(1)
(21)
(6)
(8)
(23)
(100)
48
Debt Repayment
(13)
(0)
(5)
(11)
(4)
(14)
(29)
(0)
(0)
(0)
Common Stock Issued
- -
- -
39
0
8
18
53
- -
158
189
Common Stock Repurchased
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Financing Activities
18
- -
1
16
21
16
26
0
5
(3)
Cash Used/Provided by Financing Activities
5
(0)
36
4
25
20
50
(0)
163
186
Effect of Forex Changes on Cash
- -
- -
- -
- -
0
0
0
(1)
0
(0)
Net Change In Cash
3
(1)
31
(7)
(13)
(0)
38
(26)
96
214
Cash at the End of Period
6
5
36
30
17
17
65
38
135
349
Cash at the Beginning of Period
2
6
5
36
30
17
26
65
38
135
Free Cash Flow
(2)
(1)
(4)
(11)
(17)
(14)
(11)
(6)
23
(40)
Forex Rate
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -